Total Payments
$635,979
2024 Payments
$55,824
Companies
34
Transactions
684
Medicare Patients
115
Medicare Billing
$23,978
Payment Breakdown by Category
Other$314,493 (49.5%)
Consulting$200,522 (31.5%)
Research$59,141 (9.3%)
Travel$49,636 (7.8%)
Food & Beverage$11,658 (1.8%)
Education$530.10 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $288,188 | 131 | 45.3% |
| Consulting Fee | $200,522 | 66 | 31.5% |
| Unspecified | $59,141 | 59 | 9.3% |
| Travel and Lodging | $49,636 | 174 | 7.8% |
| Honoraria | $26,305 | 10 | 4.1% |
| Food and Beverage | $11,658 | 232 | 1.8% |
| Education | $530.10 | 12 | 0.1% |
Payments by Type
General
$576,838
625 transactions
Research
$59,141
58 transactions
Ownership
$0
1 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Grifols USA, LLC | $175,821 | 133 | $0 (2024) |
| Shire North American Group Inc | $149,986 | 145 | $0 (2019) |
| GlaxoSmithKline, LLC. | $120,615 | 107 | $0 (2024) |
| ADMA BioManufacturing LLC | $59,093 | 66 | $0 (2023) |
| Takeda Pharmaceuticals U.S.A., Inc. | $44,066 | 32 | $0 (2024) |
| CSL Behring | $40,981 | 77 | $0 (2024) |
| Circassia Pharmaceuticals Inc | $14,300 | 1 | $0 (2017) |
| AIMMUNE THERAPEUTICS, INC. | $7,580 | 7 | $0 (2021) |
| GENZYME CORPORATION | $7,429 | 9 | $0 (2023) |
| Bio Products Laboratory, Inc. | $6,046 | 2 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $55,824 | 73 | Grifols USA, LLC ($32,395) |
| 2023 | $164,746 | 175 | Grifols USA, LLC ($64,170) |
| 2022 | $73,782 | 73 | Grifols USA, LLC ($33,915) |
| 2021 | $98,620 | 77 | GlaxoSmithKline, LLC. ($32,099) |
| 2020 | $40,726 | 36 | Grifols USA, LLC ($14,015) |
| 2019 | $47,504 | 66 | Shire North American Group Inc ($31,737) |
| 2018 | $71,259 | 99 | Shire North American Group Inc ($55,854) |
| 2017 | $83,519 | 85 | Shire North American Group Inc ($62,396) |
All Payment Transactions
684 individual payment records from CMS Open Payments — Page 1 of 28
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/03/2024 | Kedrion Biopharma, Inc. | Albuked (Biological), KOATE, GAMMAKED | Food and Beverage | Cash or cash equivalent | $23.51 | General |
| Category: Critical Care | ||||||
| 11/20/2024 | Grifols USA, LLC | Xembify (Biological) | Food and Beverage | In-kind items and services | $17.54 | General |
| Category: Immunology and Neurology | ||||||
| 11/19/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,300.00 | General |
| Category: RESPIRATORY | ||||||
| 11/15/2024 | Grifols USA, LLC | Xembify (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,990.00 | General |
| Category: Immunology and Neurology | ||||||
| 11/15/2024 | Grifols USA, LLC | Xembify (Biological) | Travel and Lodging | In-kind items and services | $348.08 | General |
| Category: Immunology and Neurology | ||||||
| 11/15/2024 | Grifols USA, LLC | Xembify (Biological) | Travel and Lodging | In-kind items and services | $288.95 | General |
| Category: Immunology and Neurology | ||||||
| 11/15/2024 | Grifols USA, LLC | Xembify (Biological) | Travel and Lodging | Cash or cash equivalent | $77.28 | General |
| Category: Immunology and Neurology | ||||||
| 11/15/2024 | Grifols USA, LLC | Xembify (Biological) | Travel and Lodging | Cash or cash equivalent | $64.00 | General |
| Category: Immunology and Neurology | ||||||
| 11/15/2024 | Grifols USA, LLC | Xembify (Biological) | Food and Beverage | Cash or cash equivalent | $24.14 | General |
| Category: Immunology and Neurology | ||||||
| 11/15/2024 | Grifols USA, LLC | Xembify (Biological) | Travel and Lodging | Cash or cash equivalent | $5.00 | General |
| Category: Immunology and Neurology | ||||||
| 11/08/2024 | Grifols USA, LLC | Xembify (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,990.00 | General |
| Category: Immunology and Neurology | ||||||
| 11/08/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,300.00 | General |
| Category: RESPIRATORY | ||||||
| 11/08/2024 | Grifols USA, LLC | Xembify (Biological) | Travel and Lodging | In-kind items and services | $392.51 | General |
| Category: Immunology and Neurology | ||||||
| 11/08/2024 | Grifols USA, LLC | Xembify (Biological) | Travel and Lodging | Cash or cash equivalent | $362.74 | General |
| Category: Immunology and Neurology | ||||||
| 11/08/2024 | Grifols USA, LLC | Xembify (Biological) | Travel and Lodging | In-kind items and services | $337.95 | General |
| Category: Immunology and Neurology | ||||||
| 11/08/2024 | Grifols USA, LLC | Xembify (Biological) | Food and Beverage | Cash or cash equivalent | $25.00 | General |
| Category: Immunology and Neurology | ||||||
| 11/08/2024 | Grifols USA, LLC | Xembify (Biological) | Travel and Lodging | Cash or cash equivalent | $10.00 | General |
| Category: Immunology and Neurology | ||||||
| 11/07/2024 | PFIZER INC. | OCTAGAM IMMUNE GLOBULIN (HUMAN) (Drug), PANZYGA, CUTAQUIG | Food and Beverage | In-kind items and services | $25.75 | General |
| Category: IMMUNOLOGY | ||||||
| 11/06/2024 | HOSPIRA, INC. | OCTAGAM IMMUNE GLOBULIN (HUMAN) (Drug), PANZYGA, CUTAQUIG | Food and Beverage | In-kind items and services | $16.64 | General |
| Category: IMMUNOLOGY | ||||||
| 10/24/2024 | Blueprint Medicines Corporation | AYVAKIT (Drug) | Food and Beverage | In-kind items and services | $125.29 | General |
| Category: Oncology / Rare Diseases | ||||||
| 10/21/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,300.00 | General |
| Category: RESPIRATORY | ||||||
| 09/14/2024 | Grifols USA, LLC | Xembify (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,990.00 | General |
| Category: Immunology and Neurology | ||||||
| 09/14/2024 | Grifols USA, LLC | Xembify (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,425.00 | General |
| Category: Immunology and Neurology | ||||||
| 09/14/2024 | Grifols USA, LLC | Xembify (Biological) | Travel and Lodging | In-kind items and services | $881.40 | General |
| Category: Immunology and Neurology | ||||||
| 09/14/2024 | Grifols USA, LLC | Xembify (Biological) | Travel and Lodging | In-kind items and services | $464.14 | General |
| Category: Immunology and Neurology | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A Randomized, Multi-Center, Single-Visit, Clinical Investigation to Assess the Degree of Agreement and Feasibility of Measuring Exhaled Nitric Oxide in Children, Aged 4-6 Years Old, With the NIOX VERO Using the 6 Second Exhalation Mode as Compared With the 10 Second Exhalation Mode | Circassia Pharmaceuticals Inc | $14,300 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 21 | 52 | $11,196 | $4,323 |
| 2022 | 2 | 33 | 71 | $10,648 | $5,429 |
| 2021 | 2 | 34 | 105 | $15,868 | $8,723 |
| 2020 | 2 | 27 | 82 | $12,400 | $5,503 |
Total Patients
115
Total Services
310
Medicare Billing
$23,978
Procedure Codes
7
All Medicare Procedures & Services
7 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 21 | 52 | $11,196 | $4,323 | 38.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 21 | 49 | $6,468 | $3,179 | 49.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 12 | 22 | $4,180 | $2,251 | 53.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 18 | 69 | $9,028 | $5,131 | 56.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 16 | 36 | $6,840 | $3,592 | 52.5% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 12 | 53 | $6,890 | $2,997 | 43.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 15 | 29 | $5,510 | $2,506 | 45.5% |
About Richard Wasserman, MD, PHD
Richard Wasserman, MD, PHD is a Allergy & Immunology healthcare provider based in Dallas, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/01/2005. The National Provider Identifier (NPI) number assigned to this provider is 1346234614.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Richard Wasserman, MD, PHD has received a total of $635,979 in payments from pharmaceutical and medical device companies, with $55,824 received in 2024. These payments were reported across 684 transactions from 34 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($288,188).
As a Medicare-enrolled provider, Wasserman has provided services to 115 Medicare beneficiaries, totaling 310 services with total Medicare billing of $23,978. Data is available for 4 years (2020–2023), covering 7 distinct procedure/service records.
Ad
Practice Information
- Specialty Allergy & Immunology
- Location Dallas, TX
- Active Since 09/01/2005
- Last Updated 11/13/2023
- Taxonomy Code 207K00000X
- Entity Type Individual
- NPI Number 1346234614
Products in Payments
- Xembify (Biological) $170,510
- HYQVIA (Biological) $79,578
- TRELEGY ELLIPTA (Drug) $58,215
- Bivigam (Drug) $44,841
- CUVITRU (Biological) $43,603
- AREXVY (Drug) $42,439
- CINRYZE (Drug) $37,000
- Hizentra (Biological) $35,648
- NIOX VERO DEVICE (Device) $14,300
- Gammaplex 10% (Biological) $6,046
- Gamunex-C (Biological) $5,372
- PALFORZIA (Biological) $5,180
- DUPIXENT (Biological) $2,050
- PAXLOVID (Drug) $1,200
- OCTAGAM IMMUNE GLOBULIN (HUMAN) (Drug) $454.55
- NUCALA (Biological) $292.06
- Auvi-Q (Drug) $225.50
- FASENRA (Drug) $221.39
- FASENRA (Biological) $160.39
- Xolair (Biological) $157.48
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Allergy & Immunology Doctors in Dallas
Matthew Feldman, Md, MD
Allergy & Immunology — Payments: $457,527
Allergy & Immunology $457,527
Lara Gross, Md, MD
Allergy & Immunology — Payments: $98,292
Allergy & Immunology $98,292
Dr. Sonak Daulat, M.d, M.D
Allergy & Immunology — Payments: $69,124
Allergy & Immunology $69,124
Dr. Elliot Ginchansky, M.d, M.D
Allergy & Immunology — Payments: $55,842
Allergy & Immunology $55,842
Dr. Sandeep Reddy, Md, MD
Allergy & Immunology — Payments: $36,350
Allergy & Immunology $36,350
Dr. Anil Nanda, M.d, M.D
Allergy & Immunology — Payments: $25,676
Allergy & Immunology $25,676